FeesSafety
Pluang+

Osisko Metals reports strong copper drill results at Gaspé, including 314m averaging 0.44% Cu with high-grade zones.

Market News
03 Nov 2026, 13:00 WIB
GlobeNewsWire
View Source
Bullish
Osisko Metals reports strong copper drill results at Gaspé, including 314m averaging 0.44% Cu with high-grade zones.

Osisko Metals announced new drill results from its 2026 program at the Gaspé Copper Project in Québec, highlighting a 314-metre intercept averaging 0.44% copper, including a high-grade 9-metre section with 3.23% copper and 16.7 g/t silver. These results support resource upgrades and expansion potential, especially towards the south and southwest of the current mineral resource model. The company aims to convert inferred resources to measured and indicated categories while exploring lateral extensions. This progress reinforces Gaspé's status as the largest undeveloped copper resource in eastern North America, with ongoing drilling to further define and expand the deposit.

Osisko Metals' recent drill results at the Gaspé Copper Project provide context for readers following mining developments. For readers following Basic Materials-sector stocks on Pluang, here is the market snapshot as of Nov 03, 2026 17:51 WIB: out of 83 priced US stocks, 22 rose and 57 fell. Notable movers include Sasol Ltd. American Depositary Shares (SSL) at USD 16.29 with a 1-day change of +3.04% and a typical hold time of 5 days, Teck Resources (TECK) at USD 61.00 down 2.77% with a typical hold time of 22 days, and Endeavour Silver Corp (EXK) at USD 7.03 down 2.77%, with Pluang order activity showing 38% Sell and 62% Buy and a typical hold time of 28 days.

More News

Anavex names Terrie Kellmeyer CEO to lead clinical growth and FDA engagement

Anavex names Terrie Kellmeyer CEO to lead clinical growth and FDA engagement

Anavex Life Sciences appointed Terrie Kellmeyer, Ph.D., as President and CEO, also joining the Board. Kellmeyer, with over 30 years in biopharma, has led the company through key clinical milestones including FDA clearance for Fragile X syndrome trial...

Company Fundamentals
Bullish
1 hour ago
Cardiff Oncology to present at UBS Global Biopharma Conference on Nov 16-17, 2026

Cardiff Oncology to present at UBS Global Biopharma Conference on Nov 16-17, 2026

Cardiff Oncology, a clinical-stage biotech company focusing on cancer therapies via PLK1 inhibition, announced it will present at the UBS Global Biopharma Conference on November 16-17, 2026. The company's CEO, Mani Mohindru, will deliver a fireside c...

Market News
Bullish
1 hour ago
Seyond expands smart city tech with LiDAR-powered operational twins and AI collaborations

Seyond expands smart city tech with LiDAR-powered operational twins and AI collaborations

Seyond Inc is enhancing its smart city solutions by integrating advanced LiDAR 3D sensing with AI-powered analytics and collaborations with Dell Technologies, NVIDIA, and AMSYS. This expansion supports improved safety, transportation, and infrastruct...

Market News
Bullish
1 hour ago
Stella-Jones schedules Q3 2026 earnings call for Nov 4, open to investors and analysts.

Stella-Jones schedules Q3 2026 earnings call for Nov 4, open to investors and analysts.

Stella-Jones Inc. announced a teleconference on November 4, 2026, at 10:00 AM EST to discuss its third-quarter 2026 financial results. The event is open to investors, analysts, and interested parties, with live streaming and phone access provided. A ...

Company Fundamentals
Neutral
2 hours ago
Stella-Jones to hold Q3 2026 financial results conference call on Nov 4

Stella-Jones to hold Q3 2026 financial results conference call on Nov 4

Stella-Jones Inc. announced a conference call for November 4, 2026, at 10:00 AM EST to discuss its third quarter 2026 financial results. The call is open to investors, analysts, and interested parties and will be webcast live with a recording availab...

Company Fundamentals
Neutral
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App